[1]
Fayyazi, N.; Esmaeili, S.; Taheri, S.; Ribeiro, F.F.; Scotti, M.T.; Scotti, L.; Ghasemi, J.B.; Fassihi, A.; Saghaei, L. Pharmacophore modeling, synthesis, scaffold hopping and biological β-hematin inhibition interaction studies for anti-malaria compounds. Curr. Top. Med. Chem., 2019, 19(30), 2743-2765.
[2]
Limaye, A.; Sweta, J.; Mudgal, U.; Mukherjee, S.; Sharma, S.; Hussain, T.; Nayarisseri, A.; Singh, S.K. In silico insights on GD2: a potential target for pediatric neuroblastoma. Curr. Top. Med. Chem., 2019, 19(30), 2766-2781.
[3]
Tahir, R.A.; Hassan, F.; Kareem, A.; Iftikhar, U.; Sehgal, S.A. Ligand-based pharmacophore modeling and virtual screening to discover novel CYP1A1 inhibitors. Curr. Top. Med. Chem., 2019, 19(30), 2782-2794.
[4]
Rodrigues, R.P.; Ardisson, J.S. de C.R. Gonçalves, R.; Oliveira, T.B.; da Silva, V.B.; Kawano, D.F.; Kitagawa, R.R. Search for potential inducible nitric oxide synthase inhibitors with favorable ADMET profiles for the therapy of helicobacter pylori infections. Curr. Top. Med. Chem., 2019, 19(30), 2795-2804.